CODEXIS INC. - COMMON

Codexis Announces New Employment Inducement Grants

15 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23

09 Feb 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Appointment of Sri Ryali as Chief Financial Officer

23 Jan 2023 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Appointment of H. Stewart Parker to Board of Directors

20 Dec 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis Provides Update on Prioritized Corporate Strategy

29 Nov 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis to Participate in Piper Sandler 34th Annual Healthcare Conference

16 Nov 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Healthcare Conferences

08 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

Codexis Reports Third Quarter 2022 Financial Results

03 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

Codexis Announces Appointment of Margaret Fitzgerald as Chief Legal Officer and General Counsel

01 Nov 2022 08:00:03 By Nasdaq GlobeNewswire

Codexis to Report Third Quarter 2022 Financial Results on November 3

20 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer

03 Oct 2022 08:00:02 By Nasdaq GlobeNewswire

Codexis Announces Appointment of Rahul Singhvi, Sc.D., to Board of Directors

03 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Codexis’ 2022 Protein Engineering Forum Showcases Recent Industry Success and Emerging Innovations in the Field

14 Sep 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis Reports Second Quarter 2022 Financial Results

04 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis

02 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Codexis Announces CEO Transition Effective August 9, 2022

18 Jul 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces Agreement with Pfizer to Supply Enzyme for the Manufacture of PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)

14 Jul 2022 16:06:00 By Nasdaq GlobeNewswire

Codexis Announces Preliminary Second Quarter 2022 Results and Updates Guidance

14 Jul 2022 16:05:00 By Nasdaq GlobeNewswire

Codexis Announces the Publication of Research Demonstrating Proof of Concept for Chemoenzymatic Site-Selective Bioconjugation of Native Peptides

17 Jun 2022 08:00:00 By Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Healthcare Conferences

25 May 2022 16:05:00 By Nasdaq GlobeNewswire